These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36226726)

  • 1. Female pattern hair loss and polycystic ovarian syndrome: more than just hirsutism.
    Jiang VS; Hawkins SD; McMichael A
    Curr Opin Endocrinol Diabetes Obes; 2022 Dec; 29(6):535-540. PubMed ID: 36226726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome and acne.
    Chuan SS; Chang RJ
    Skin Therapy Lett; 2010; 15(10):1-4. PubMed ID: 21076799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian surgery for symptom relief in women with polycystic ovary syndrome.
    Lepine S; Jo J; Metwally M; Cheong YC
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD009526. PubMed ID: 29125183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen excess: Investigations and management.
    Lizneva D; Gavrilova-Jordan L; Walker W; Azziz R
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():98-118. PubMed ID: 27387253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based approach to cutaneous hyperandrogenism in women.
    Schmidt TH; Shinkai K
    J Am Acad Dermatol; 2015 Oct; 73(4):672-90. PubMed ID: 26138647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
    Carmina E; Azziz R; Bergfeld W; Escobar-Morreale HF; Futterweit W; Huddleston H; Lobo R; Olsen E
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2875-2891. PubMed ID: 30785992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair loss in women.
    Camacho-Martínez FM
    Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.
    Unluhizarci K; Kaltsas G; Kelestimur F
    Eur J Clin Invest; 2012 Jan; 42(1):86-94. PubMed ID: 21623779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical evaluation of hirsutism.
    Somani N; Harrison S; Bergfeld WF
    Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female Pelvic Conditions: Polycystic Ovary Syndrome.
    Wilkinson LD; Brady PH; Gin GT; Rosenblum E
    FP Essent; 2022 Apr; 515():26-31. PubMed ID: 35420404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients.
    Hong JS; Kwon HH; Park SY; Jung JY; Yoon JY; Min S; Choi YM; Suh DH
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):42-7. PubMed ID: 24628922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirsutism: diagnosis and treatment.
    Hohl A; Ronsoni MF; Oliveira Md
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):97-107. PubMed ID: 24830586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome: a dermatologic approach.
    Moura HH; Costa DL; Bagatin E; Sodré CT; Manela-Azulay M
    An Bras Dermatol; 2011; 86(1):111-9. PubMed ID: 21437531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
    West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
    Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.